Engelson Erik T. - 16 Jun 2022 Form 4 Insider Report for Lucira Health, Inc.

Role
President and Chief Executive, Director
Signature
/s/ Dan George, Attorney-in-Fact for Erik T. Engelson
Issuer symbol
N/A
Transactions as of
16 Jun 2022
Net transactions value
+$14,900
Form type
4
Filing time
17 Jun 2022, 18:45:29 UTC
Previous filing
16 Mar 2022
Next filing
19 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Purchase $14,900 +10,000 +19% $1.49* 63,282 16 Jun 2022 Direct F1
holding LHDXQ Common Stock 46,400 16 Jun 2022 See footnote F2
holding LHDXQ Common Stock 191,705 16 Jun 2022 See footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.45 to $1.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 The shares are held by the Elisabeth North Kuechler Engelson Trust, dated January 17, 2001, for which Mr. Engelson serves as trustee.
F3 The shares are held by Epic Pacific, LLC, of which Mr. Engelson is a Member. Mr. Engelson disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.